| 1993 |
Rab9 localizes primarily to the surface of late endosomes and, when prenylated in vitro, stimulates transport of mannose 6-phosphate receptors (MPRs) from late endosomes to the trans-Golgi network (TGN) in a cell-free reconstitution system; C-terminally truncated Rab9 was inactive, and Rab7 (also on late endosomes) was inactive in this assay despite efficient prenylation and GTP binding. |
In vitro prenylation, cell-free transport reconstitution assay, subcellular fractionation |
The EMBO journal |
High |
8440258
|
| 1993 |
Rab9 GTPase activity: purified recombinant Rab9 hydrolyzes GTP (kcat ~0.0052 min⁻¹ at 37°C) and has nucleotide association/dissociation kinetics distinct from the closely related Rab7, providing the first biochemical characterization of this enzyme. |
In vitro GTPase assay, nucleotide binding kinetics with purified recombinant protein |
The Journal of biological chemistry |
High |
8463223
|
| 1993 |
Cytosolic Rab9 exists as an ~80 kDa complex with GDI (GDP dissociation inhibitor); complex formation requires Rab9 carboxy-terminal geranylgeranylation, and purified Rab3A-GDI can solubilize Rab9-GDP but not Rab9-GTP from membranes, supporting a model in which GDI recycles Rab9 from target membranes after each transport cycle. |
In vitro prenylation, gel filtration/sedimentation, GDI extraction assay with purified components |
Molecular biology of the cell |
High |
8389620
|
| 1994 |
Dominant-negative Rab9 S21N expressed in living cells specifically blocks MPR recycling from late endosomes to the TGN, leading to decreased lysosomal enzyme sorting efficiency; biosynthetic transport, fluid-phase endocytosis, and receptor-mediated endocytosis were unaffected. |
Dominant-negative mutant expression in living cells, pulse-chase and secretion assays |
The Journal of cell biology |
High |
7909812
|
| 1994 |
Selective targeting of prenylated Rab9 onto late endosome membranes is reconstituted in vitro from GDI-Rab9 complexes and is accompanied by endosome-triggered GDP-to-GTP nucleotide exchange, demonstrating that membrane delivery and activation are coupled. |
In vitro membrane recruitment reconstitution, nucleotide exchange assay with purified prenylated Rab9-GDI complexes |
Nature |
High |
8164745
|
| 1994 |
Rab9-GDI complexes represent a functional cytosolic pool that can be used for late-endosome-to-TGN transport; immunodepletion of GDI abolishes cytosol transport activity restored by re-addition of pure Rab9-GDI; GDI increases selectivity of Rab9 membrane targeting compared to albumin-delivered Rab9. |
Immunodepletion of cytosol, reconstitution with purified Rab9-GDI, cell-free transport assay |
The Journal of biological chemistry |
High |
8195183
|
| 1995 |
Rab9 and Rab7, both late endosomal, are recruited onto late endosome membranes by biochemically distinguishable machinery: Rab9-GDI complexes competitively inhibit Rab9 recruitment with ~9 nM Ki but inhibit Rab7 recruitment much less effectively (~112 nM Ki), and vice versa, demonstrating that a single organelle bears multiple distinct Rab recruitment machines. |
In vitro Rab recruitment competition assay with purified prenylated Rab-GDI complexes |
The Journal of biological chemistry |
High |
7592724
|
| 1997 |
p40, a novel 40-kDa Rab9 effector identified by yeast two-hybrid, binds Rab9-GTP with ~4-fold preference over Rab9-GDP, co-fractionates with late endosomes and Rab9, and potently stimulates MPR transport from endosomes to TGN in a cell-free assay; anti-p40 antibodies inhibit transport, and p40 shows synergy with Rab9. |
Yeast two-hybrid, subcellular fractionation, in vitro transport assay with purified recombinant p40, antibody inhibition |
The Journal of cell biology |
High |
9230071
|
| 2001 |
TIP47 (tail-interacting protein of 47 kDa) binds directly to GTP-bound (active) Rab9, and Rab9 increases the affinity of TIP47 for MPR cytoplasmic domains; a functional Rab9-binding site in TIP47 is required for TIP47 stimulation of MPR transport in vivo, demonstrating that Rab9 couples cargo selection to organelle identity. |
Direct binding assay (GST pulldown), affinity measurements, dominant-negative and binding-mutant rescue in living cells |
Science |
High |
11359012
|
| 2002 |
GFP-Rab9 localizes to late endosomes and occupies distinct membrane domains from Rab7 on the same organelle; cation-independent MPRs are enriched in Rab9 domains; Rab9-positive transport vesicles undergo bidirectional microtubule-dependent motility and fuse with the TGN, and Rab9 is rapidly removed coincident with or just after membrane fusion. |
GFP live-cell imaging, video microscopy, co-expression with fluorescent Rab7, fixed-cell colocalization |
The Journal of cell biology |
High |
11827983
|
| 2002 |
TIP47 residues 161–169 are essential (but not sufficient) for Rab9 binding; mutations in this region decrease Rab9 binding without altering overall protein folding or MPR cytoplasmic domain binding, identifying distinct binding surfaces for Rab9 and cargo in TIP47. |
Site-directed mutagenesis, GST pulldown, circular dichroism spectroscopy, partial proteolysis |
Proceedings of the National Academy of Sciences |
High |
12032303
|
| 2003 |
PIKfyve (a lipid/protein kinase) interacts with the Rab9 effector p40 via its chaperonin domain and p40 kelch repeats; kinase-dead PIKfyve depletes p40 from membranes, and PIKfyve phosphorylates p40 on serine in vitro, suggesting PIKfyve-mediated phosphorylation anchors p40 to late endosome membranes to support endosome-to-TGN transport. |
Yeast two-hybrid, GST pulldown, co-immunoprecipitation in HEK293 cells, differential centrifugation, in vitro kinase assay |
The Journal of biological chemistry |
High |
14530284
|
| 2004 |
RNAi depletion of Rab9 decreases late endosome size, reduces multilamellar and dense-tubule-containing late endosomes/lysosomes, increases surface MPRs, causes MPR missorting to lysosomes, and clusters remaining late endosomes near the nucleus; additionally, Rab9 stability on late endosomes requires its interaction with the effector TIP47. |
siRNA knockdown, quantitative morphological analysis by EM, flow cytometry for surface MPRs, pulse-chase |
Molecular biology of the cell |
High |
15456905
|
| 2006 |
TIP47 concentration controls Rab9 localization: Rab5/9 and Rab1/9 chimeras that can bind both parental Rab effectors shift localization toward Rab9 compartments when TIP47 levels are elevated, demonstrating that effector concentration is a determinant of Rab steady-state localization. |
Chimeric Rab construction, quantitative effector binding assay, fluorescence microscopy with modulation of TIP47 levels |
The Journal of cell biology |
High |
16769818
|
| 2006 |
Cholesterol accumulation in NPC1-deficient cells sequesters Rab9 in an inactive state on endosome membranes by reducing GDI-mediated extraction (shown by cholesterol-dose-dependent decrease in GDI extractability of prenylated Rab9 from liposomes); sequestered Rab9 leads to MPR missorting, reversed by Rab9 overexpression. |
NPC1 cell fractionation, GDI extraction assay, liposome assay with increasing cholesterol, GFP-Rab9 rescue |
The Journal of biological chemistry |
High |
16644737
|
| 2010 |
BLOC-3 (HPS1-HPS4 heterodimer) interacts specifically and strongly with GTP-bound Rab9 through HPS4 and the switch I/II regions of Rab9, identifying BLOC-3 as a Rab9A effector involved in biogenesis of lysosome-related organelles. |
Recombinant protein production, analytical ultracentrifugation, GST pulldown/interaction screen with Rab9 nucleotide-state specificity |
The Journal of biological chemistry |
High |
20048159
|
| 2011 |
RUTBC1 (a TBC-domain protein) binds Rab9A-GTP in vitro and in cells but is not a GAP for Rab9A; instead it acts as a GAP for Rab32 and Rab33B (requiring catalytic Arg-803, consistent with dual-finger mechanism), linking Rab9A function to regulation of adjacent Rab32 pathway. |
GST pulldown, co-immunoprecipitation, in vitro GAP assay with Rab protein substrates, mutagenesis (R803A), effector binding assay in cells |
The Journal of biological chemistry |
High |
21808068
|
| 2011 |
Rab9 and its effector GCC185 (a TGN golgin) are required for retrograde transport of furin from late endosomes to the TGN; furin transits early and late endosomes en route to the TGN, and its diversion to the early-endosome retromer pathway requires both the transmembrane domain and cytoplasmic tail of TGN38, implicating transmembrane domain length in endosomal sorting. |
Internalization assays, dominant-negative Rab9, siRNA knockdown of Rab9/GCC185, chimeric receptor trafficking analysis |
Journal of cell science |
High |
21693586
|
| 2012 |
RUTBC2 (a TBC-domain protein) binds Rab9A-GTP specifically in vitro and in cells but is not a GAP for Rab9A; it acts as a GAP for Rab34 and Rab36 (requiring catalytic R829), and wild-type RUTBC2 but not R829A decreases membrane-associated Rab36 in cells, linking Rab9A to Rab36 regulation in the endosomal system. |
GST pulldown, co-immunoprecipitation, in vitro GAP assay with multiple Rab substrates, mutagenesis, co-localization |
The Journal of biological chemistry |
High |
22637480
|
| 2019 |
During myocardial ischemia, mitophagy is mediated by Rab9-associated autophagosomes (alternative autophagy independent of Atg7/LC3); this involves a complex of Ulk1, Rab9, Rip1, and Drp1; Ulk1 phosphorylates Rab9 at S179 and Rip1 phosphorylates Drp1 at S616, recruiting trans-Golgi membranes to damaged mitochondria. Rab9 S179A knockin abolishes alternative mitophagy and exacerbates ischemic injury without affecting conventional autophagy. |
Knockin mouse (Rab9 S179A), co-immunoprecipitation of Ulk1/Rab9/Rip1/Drp1 complex, phosphorylation assays, in vivo ischemia model with mitophagy readouts |
The Journal of clinical investigation |
High |
30511961
|
| 2019 |
HPS4 (BLOC-3 subunit) Rab32/38-GEF activity is essential for melanogenesis, but its Rab9-binding activity is dispensable; site-directed HPS4 mutants specifically lacking Rab9 binding fully rescued hypopigmentation in HPS4-deficient melan-le cells, showing Rab9 regulates melanogenesis independently of BLOC-3. |
Site-directed mutagenesis of HPS4, rescue of HPS4-deficient melanocyte cell line, melanin content and tyrosinase trafficking assays |
The Journal of biological chemistry |
High |
30837268
|
| 2021 |
Nde1/Ndel1 is a Rab9A effector that tethers Rab9-positive late endosomes to the cytoplasmic dynein motor complex for retrograde transport; crystal structure of Rab9A-GTP in complex with the Rab9-binding region of Nde1 was determined, and key interface residues were validated biochemically; Rab9A mutants unable to bind Nde1 also failed to associate with dynein, Lis1, and dynactin. |
Crystal structure determination, biochemical pulldown, co-immunoprecipitation, mutagenesis of interface residues, cell biology assays |
Structure |
High |
34793709
|
| 2009 |
Rab9 interacts with the intermediate filament protein vimentin; in NPC1 cells, lipid accumulation inhibits PKC, causing vimentin hypophosphorylation, intermediate filament aggregation, and entrapment of Rab9, which leads to late endosome transport defects and impaired lipid egress. |
Co-immunoprecipitation/pulldown for Rab9-vimentin interaction, PKC activity assay, phosphorylation analysis, lipid transport assay in NPC1 cells |
Biology of the cell |
Medium |
18681838
|
| 2010 |
Rab9 co-localizes in vesicular structures with TRPC6 and co-immunoprecipitates with TRPC6; dominant-negative Rab9 S21N increases TRPC6 at the plasma membrane and enhances TRPC6-mediated Ca²⁺ entry, indicating Rab9-dependent late endosomal trafficking regulates TRPC6 surface density. |
Co-localization by confocal microscopy, co-immunoprecipitation, dominant-negative expression, Ca²⁺ entry measurements |
Biochimica et biophysica acta |
Medium |
20346379
|
| 2016 |
Live imaging of constitutively active Rab9Q66L shows it localizes predominantly to late endosomes, disperses TGN46 and CI-MPR from the Golgi, and that CI-MPR and Rab9 enter the endosomal pathway together at the Rab5-to-Rab7 transition stage; CI-MPR vesicles attach and detach from Rab9-positive endosomal domains within seconds. |
Confocal live-cell imaging, constitutively active mutant (Rab9Q66L), CI-MPR retrograde transport assays |
Traffic |
Medium |
26663757
|
| 2017 |
PKC activation promotes α1B-adrenoceptor transfer to late endosomes through Rab9 interaction; FRET imaging shows transient receptor-Rab5 interaction followed by sustained receptor-Rab9 interaction; dominant-negative Rab9-GDP abolishes receptor traffic and alters desensitization, implicating Rab9 in GPCR heterologous desensitization. |
FRET imaging, confocal microscopy, dominant-negative Rab9, PKC inhibition, Ca²⁺ quantitation |
Molecular pharmacology |
Medium |
28082304
|
| 2023 |
NDP52 (CALCOCO2) forms a complex with Rab9 and HBV envelope proteins and links HBV to Rab9-dependent lysosomal degradation, inhibiting viral replication; this process is independent of galectin-8 and ATG5 (unlike antibacterial NDP52 autophagy), identifying a non-canonical antiviral lysosomal degradation pathway requiring Rab9. |
Co-immunoprecipitation, siRNA knockdown of Rab9, viral replication assays, lysosome targeting assays in hepatocytes |
Nature communications |
High |
38114531
|
| 2023 |
GDP-bound (not GTP-bound) Rab9a supports retromer-mediated endosomal exit of HPV during virus entry; GTP-Rab9a inhibits HPV-retromer association and impairs endosome-to-Golgi transport; Rab9a acts upstream of Rab7 in this process and can regulate HPV-retromer interaction independently of Rab7. |
siRNA knockdown, dominant-negative and constitutively active Rab9a mutants, proximity assays, retromer co-immunoprecipitation, viral entry assays |
PLoS pathogens |
High |
37703297
|
| 2024 |
TMEM9 (a lysosomal transmembrane protein) activates Rab9-dependent alternative autophagy by binding Beclin1 via its cytosolic Bcl-2-binding domain, displacing Bcl-2 and activating the Beclin1 complex at Rab9-positive autophagosomes; TMEM9 glycosylation required for lysosomal localization is essential for this interaction. |
Co-immunoprecipitation, mutagenesis of Bcl-2-binding domain, co-localization imaging, glycosylation mutants, autophagy flux assays |
Cellular and molecular life sciences |
Medium |
39078420
|
| 2026 |
GDP-bound Rab9a contains a conformation-dependent hydrophobic (CDH) degron in its switch I region that is recognized by the protein quality control (PQC) machinery; GDP-Rab9a has an extremely short half-life relative to Rab7; VCP/p97 was identified as a CDH degron-dependent PQC factor; forced accumulation of CDH-degron-mutated Rab9a causes defective CI-MPR localization, demonstrating that rapid turnover of GDP-Rab9a is required for proper vesicular trafficking. |
Protein stability assays, amino acid sequence/structural comparison, mutagenesis of switch I hydrophobic residues, CI-MPR localization assays, VCP/p97 identification |
The Journal of biological chemistry |
High |
41628772
|